Introduction
In December 1968 we began a controlled study of the use of oral contraceptives by women admitted to hospital for primary treatment of breast cancer or for biopsy of a breast lump. In 1971 we reported some preliminary findings at the Second National Conference on Breast Cancer, Los Angeles, which related to the 436 patients (54 with breast cancer, 166 with benign breast disease, and 216 matched controls) who had been interviewed up to the end of 1970 . We now present a more detailed analysis of this material to which we have 
Subjects and Method
Permission to interview women with breast disease and other control patients was obtained from the medical staff committees at five London teaching hospitals (University College Hospital, the Royal Free Hospital, the Middlesex Hospital, Charing Cross Hospital, Guy's Hospital). At each of these hospitals arrangements were made for all women who (a) were aged 16-39 years, (b) had ever been married, and (c) were admitted to hospital for primary treatment of breast cancer or for biopsy of a breast lump to be notified.* These patients were then interviewed in hospital by one or other of two experienced medical social workers, and inquiries were made about the patient's medical, obstetric, menstrual, contraceptive, and social histories.
For each patient with breast cancer two controls were selected from among the women in the wards of the same hospital who were suffering from an acute medical or surgical condition or had been admitted to hospital for a routine elective operation. These control patients were chosen to match the patient with breast cancer in regard to age (within 5 years), having ever been married, and parity (within groups 0, 1-2, 3 or more births) and were interviewed in the same way as the affected patient. were matched with patients in both of the study series. The diagnoses of the patients in the two control series are shown in Table I . About one-fifth had an acute medical condition, twofifths had an acute surgical condition, and the remainder had been admitted to hospital for routine elective surgery.
Results

USE OF ORAL CONTRACEPTIVES
The reference point chosen to assess the contraceptive histories of the women with breast disease was the time when the presence of a lump in the breast first became known to the affected patient, with corresponding times for the controls. For example, if a patient with a benign lesion had first noticed a breast lump six months before admission to hospital her contraceptive history was determined at that time, while the history of her matched control was determined at a time six months before the control patient was admitted to hospital. It should be noted, however, that 78% of the patients with breast cancer and 60% of the patients with benign breast disease were admitted to hospital within three months of the lump first being noticed, and that the results obtained using this procedure do not differ materially from those obtained when the reference point was taken to be the date of hospital admission.
The proportion of patients in each group who had been using an oral contraceptive during the month before the lump was first noticed (or during the corresponding month for the matched controls) together with the proportions who had used an oral contraceptive only before that time or had never used one at all are shown in Table II (Pike and Morrow, 1970) Proportion of total patients using oral contraceptives during month before lump was first noticed.. Proportion of total patients using oral contraceptives only before month when lump was first noticed Proportion of total patients using oral contraceptives at any time before lump was first noticed .. benign breast disease who were "current users" of oral contraceptives with more than 24 months' total duration of use (hereafter referred to as "current long-term users of oral contraceptives") and the 29 corresponding controls, and (c) the remaining patients with benign breast disease and the remaining controls. No suggestive differences in the types of oral contraceptive used were found between the affected patients and the controls in any of these three comparisons.
USE OF OTHER METHODS OF CONTRACEPTION
Among those who had never taken oral contraceptives the use of other methods of birth control was reported more frequently by the patients with breast cancer or benign breast disease than by the controls, although none of the differences shown in the Table V reach statistical significance (the largest difference is that relating to the use of no method at all in the breast cancer group and in the corresponding controls; the value of X2 for this difference is 2-1). Clearly, however, there is no indication that the patients with breast disease had any less need for contraception than the control subjects.
COMPARABILITY OF GROUPS
The controls were selected in such a way as to ensure that they would be comparable with the patients with breast disease with respect to age, parity, whether ever married, and date and hospital of admission. They were also found to be comparable in regard to religion, country of birth, whether pregnant or in the puerperium, and whether postmenopausal. Differences were found, however, in the distribution of marital status-that is, whether currently married, widowed, divorced, or separatedsocial class, age at first pregnancy, and the frequency of a past history of breast biopsy (Table VI) SEPTEMBER 1972 finding is consistent with other reports which have shown that breast cancer incidence and mortality appear to be positively correlated with socioeconomic status (Shapiro et al., 1968; Lowe and MacMahon, 1970; Zippin and Petrakis, 1971) .
Pregnancy early in life has been shown to protect against the development of breast cancer (Valaoras et al., 1969; Lowe and MacMahon, 1970) , and the data concerning age at first pregnancy, shown in Table VI , are consistent with the earlier findings. It is of considerable interest that the patients with benign breast disease, as well as those with cancer, tended to have their first pregnancy at an older age than the corresponding matched controls. The study design included matching for parity, which accounts for the absence of any differences between the patients with breast disease and the controls in the proportions who were never pregnant. Furthermore, matching for parity would be expected to reduce the differences between the affected patients and the controls with respect to age at first pregnancy.
Benign lesions of the breast tend to be recurrent, and the finding that 14% of the patients with benign breast disease had previously had a breast biopsy in comparison with only 2% of the controls was not unexpected.
In the present context the important point is whether these differences between the patients with breast disease and the controls could have biased the oral contraceptive comparisons to any major extent. This does not, in fact, appear to be the case. The use of oral contraceptives was marginally greater among the women with broken marriages and among the women in social classes I and II than among the remaining women, was not consistently associated with age at first pregnancy, and was slightly less frequent in those with a past history of breast biopsy than in those without such a history. Three fibroadenomas with florid epithelial proliferation of the type described by Goldenberg et al. (1968) and by Brown (1970) as occurring in association with the use of oral contraceptives were found. Two of these lesions occurred in women who had never used oral contraceptives, while the third occurred in a woman who had used oral contraceptives for only one month almost two years before the presence of a lump in the breast was first discovered.
Histological review of material excised from the patients with breast cancer was unrewarding. About 85% of the tumours were of the classical scirrhous variety and no points of distinction were found between the lesions from patients who had used oral contraceptives and those from patients who had not.
Discussion
Hertz (1969) * Twelve specimens could not be traced. The routine histological reports were used to allocate these patients to the appropriate category.
t Seven of these specimens showed multiple fibroadenomas. Of these, five related to patients who had never used oral contraceptives, one to a patient who had used oral contraceptives only in the past, and one to a patient who had been currently using oral contraceptives for a total duration of three months. (Allen, 1969; Hertz, 1969; Doll, 1970; Leis, 1970 (Vessey, 1970 Fechner (1970a Fechner ( , 1970b Fechner ( , 1970c Kay, 1970) and by the Regius Department of Medicine at Oxford in conjunction with the Family Planning Association (see Vessey, 1971) .
